EURETINA 2022 Hamburg Exhibitors

Sponsors

AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, LinkedIn or Instagram.

Find us at
Booth H27

Visit Website

AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, LinkedIn or Instagram.

Agepha Pharmaceuticals

AGEPHA PHARMA is a well-established European manufacturer of pharmaceutical products for several medical fields including ophthalmology. With over 70 years of continuous research and development of innovative products, AGEPHA Pharma is today a medium-sized multinational company with a broad range of products distributed worldwide. We care about developing products that truly benefit healthcare and can improve overall quality of life. All our products are of outstanding quality due to our rigid compliance with the highest European pharmaceutical manufacturing standards.

Agepha Pharmaceuticals

AGEPHA PHARMA is a well-established European manufacturer of pharmaceutical products for several medical fields including ophthalmology. With over 70 years of continuous research and development of innovative products, AGEPHA Pharma is today a medium-sized multinational company with a broad range of products distributed worldwide. We care about developing products that truly benefit healthcare and can improve overall quality of life. All our products are of outstanding quality due to our rigid compliance with the highest European pharmaceutical manufacturing standards.

Alchimia

Alchimia is one of the leading European manufacturers of medical devices for ophthalmic surgery and human tissue banking with the aim of improving the daily routine of the medical personnel and the quality of life of patients.

Alchimia

Alchimia is one of the leading European manufacturers of medical devices for ophthalmic surgery and human tissue banking with the aim of improving the daily routine of the medical personnel and the quality of life of patients.

Alcon Management Sa

Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With an over 75-year heritage, we are the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care. Being a truly global company, we work in 60 countries and serve patients in more than 140 countries. We have a long history of industry firsts, and each year we commit a substantial amount in Research and Development to meet customer needs and patient demands

Alcon Management Sa

Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With an over 75-year heritage, we are the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care. Being a truly global company, we work in 60 countries and serve patients in more than 140 countries. We have a long history of industry firsts, and each year we commit a substantial amount in Research and Development to meet customer needs and patient demands

Alimera Sciences Europe Ltd.

Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit our website.

Alimera Sciences Europe Ltd.

Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit our website.

Apellis Switzerland GmbH

Apellis is a global biopharmaceutical company leveraging courageous science, creativity, and compassion to deliver life-changing medicines. At Apellis, we are committed to developing transformative therapies for people living with Geographic Atrophy (GA) by regulating complement, a part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat many diseases such as GA, where there are currently no treatment options available. For more information about Apellis please visit our website and if you would like to learn more about geographic atrophy, visit geographicatrophy.eu.

Apellis Switzerland GmbH

Apellis is a global biopharmaceutical company leveraging courageous science, creativity, and compassion to deliver life-changing medicines. At Apellis, we are committed to developing transformative therapies for people living with Geographic Atrophy (GA) by regulating complement, a part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat many diseases such as GA, where there are currently no treatment options available. For more information about Apellis please visit our website and if you would like to learn more about geographic atrophy, visit geographicatrophy.eu.

Aprofol AG

Aprofol AG is focused on reduced Folate for the treatment of chronic diseases. An altered microcirculation is considered a risk factor for degenerative eye diseases such as age-related macular degeneration (AMD), diabetic retinopathy (DR) and glaucoma. An inadequate microcirculation is the reason for systemic and/or local deficiencies of micronutrients e.g. bioactive Folate. Aprofol AG supported a recently published study with glaucoma patients and Ocufolin®. After 12 weeks the Homocysteine-level and the retinal venous pressure (RVP) was significantly reduced.

Aprofol AG

Aprofol AG is focused on reduced Folate for the treatment of chronic diseases. An altered microcirculation is considered a risk factor for degenerative eye diseases such as age-related macular degeneration (AMD), diabetic retinopathy (DR) and glaucoma. An inadequate microcirculation is the reason for systemic and/or local deficiencies of micronutrients e.g. bioactive Folate. Aprofol AG supported a recently published study with glaucoma patients and Ocufolin®. After 12 weeks the Homocysteine-level and the retinal venous pressure (RVP) was significantly reduced.

Bausch + Lomb

With over 169 years of innovation, Bausch+Lomb is a leading global eye care brand with expertise in contact lenses and lens care, pharmaceuticals and surgery. The Surgical Division provides a complete product portfolio for cataract, refractive, corneal and retinal surgery. This includes our combined Stellaris Elite™ system, designed to deliver optimized control and efficiency to a wide range for cataract and retinal procedures, the BiBlade® vitrectomy cutter with its dual port design and our Vitesse® hypersonic vitrectomy system for a new approach to vitreous removal. Combined with our comprehensive instrument range, we provide for individual surgeon techniques and patient needs.

Bausch + Lomb

With over 169 years of innovation, Bausch+Lomb is a leading global eye care brand with expertise in contact lenses and lens care, pharmaceuticals and surgery. The Surgical Division provides a complete product portfolio for cataract, refractive, corneal and retinal surgery. This includes our combined Stellaris Elite™ system, designed to deliver optimized control and efficiency to a wide range for cataract and retinal procedures, the BiBlade® vitrectomy cutter with its dual port design and our Vitesse® hypersonic vitrectomy system for a new approach to vitreous removal. Combined with our comprehensive instrument range, we provide for individual surgeon techniques and patient needs.

Bayer

Bayer aims to reduce the impact of visual impairment on patients through innovation. We are committed to continuing research and development to address unmet needs, including identifying ways to minimize treatment burden, increase treatment effectiveness and discover therapies for currently untreated eye diseases. We offer EYLEA®, aflibercept solution for injection, a recognized treatment for various retinal diseases, such as neovascular AMD, DME and RVO. We are expanding expertise beyond exudative eye diseases through strategic alliances and collaborations, with established partners like Regeneron Pharmaceutics, the Wilmer Eye Institute and the DND initiative. We have begun to expand into Cell & Gene Therapy cooperating with Blue Rock Therapeutics, an independently operated wholly-owned Bayer subsidiary, and have established a strategic collaboration with Opsis Therapeutics and FUJIFILM Cellular Dynamics aiming to develop cell therapies for degenerative retinal conditions, focusing on inherited retinal disorders and dry AMD, for which there are no effective treatment options.

Bayer

Bayer aims to reduce the impact of visual impairment on patients through innovation. We are committed to continuing research and development to address unmet needs, including identifying ways to minimize treatment burden, increase treatment effectiveness and discover therapies for currently untreated eye diseases. We offer EYLEA®, aflibercept solution for injection, a recognized treatment for various retinal diseases, such as neovascular AMD, DME and RVO. We are expanding expertise beyond exudative eye diseases through strategic alliances and collaborations, with established partners like Regeneron Pharmaceutics, the Wilmer Eye Institute and the DND initiative. We have begun to expand into Cell & Gene Therapy cooperating with Blue Rock Therapeutics, an independently operated wholly-owned Bayer subsidiary, and have established a strategic collaboration with Opsis Therapeutics and FUJIFILM Cellular Dynamics aiming to develop cell therapies for degenerative retinal conditions, focusing on inherited retinal disorders and dry AMD, for which there are no effective treatment options.

BVI

BVI® is refocusing the future of vision.
As one of the fastest-growing, diversified surgical ophthalmic businesses in the world, our purpose-built portfolio of trusted brands includes: Beaver® (Knives and Blades), Visitec® (Cannulas), Malosa® (Single-Use Instruments), Vitreq® (Vitreoretinal Surgical Products) and PhysIOL® (Premium IOLs), and spans more than 90 countries.
We’ve set our sights on touching the lives of millions of patients affected by conditions such as cataracts, refractive error, glaucoma, retinal disease, and dry eye. Unburdened by legacy or bureaucracy, we have developed our strategy around a simple concept – taking pride in delivering innovative solutions for our physicians and patients, based on their needs.
We trust and empower our associates to make decisions and solve problems because collaboration drives us. Valuing agility, simplicity, and transparency, we stay committed to listening to our customers, delivering for our patients, and keeping the future in focus.

BVI

BVI® is refocusing the future of vision.
As one of the fastest-growing, diversified surgical ophthalmic businesses in the world, our purpose-built portfolio of trusted brands includes: Beaver® (Knives and Blades), Visitec® (Cannulas), Malosa® (Single-Use Instruments), Vitreq® (Vitreoretinal Surgical Products) and PhysIOL® (Premium IOLs), and spans more than 90 countries.
We’ve set our sights on touching the lives of millions of patients affected by conditions such as cataracts, refractive error, glaucoma, retinal disease, and dry eye. Unburdened by legacy or bureaucracy, we have developed our strategy around a simple concept – taking pride in delivering innovative solutions for our physicians and patients, based on their needs.
We trust and empower our associates to make decisions and solve problems because collaboration drives us. Valuing agility, simplicity, and transparency, we stay committed to listening to our customers, delivering for our patients, and keeping the future in focus.

Canon Medical Systems

Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-Ray, Ultrasound and MRI, across the globe. As of December 2016, Canon Medical became a member of the Canon Group. In line with our continued Made For life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features. At Canon Medical we work hand in hand with our partners – our medical, academic and research community. We build relationships based on transparency, trust and respect. Together as one, we strive to create industry-leading solutions that deliver an enriched quality of life.

Canon Medical Systems

Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-Ray, Ultrasound and MRI, across the globe. As of December 2016, Canon Medical became a member of the Canon Group. In line with our continued Made For life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features. At Canon Medical we work hand in hand with our partners – our medical, academic and research community. We build relationships based on transparency, trust and respect. Together as one, we strive to create industry-leading solutions that deliver an enriched quality of life.

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG offers complete solutions, including implants and consumables, to diagnose and treat eye conditions and ophthalmic diseases.
The comprehensive ZEISS portfolio is designed to meet the demands of eye care professionals and help them deal with an increasingly challenging healthcare environment.
The company drives the development of leading edge technology for diagnosis, treatment, follow-up and management of the most common eye diseases - all with the goal of helping health care professionals
overcome their day-to-day challenges so they can focus on delivering the best possible patient care.

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG offers complete solutions, including implants and consumables, to diagnose and treat eye conditions and ophthalmic diseases.
The comprehensive ZEISS portfolio is designed to meet the demands of eye care professionals and help them deal with an increasingly challenging healthcare environment.
The company drives the development of leading edge technology for diagnosis, treatment, follow-up and management of the most common eye diseases - all with the goal of helping health care professionals
overcome their day-to-day challenges so they can focus on delivering the best possible patient care.

D.O.R.C. International

D.O.R.C. enhances global eye surgery and maximises surgeon control by offering innovative quality approaches for eye disorders. Our product portfolio includes EVA NEXUS™ phaco-vitrectomy system featuring unique VTi pump offering both FLOW and VACUUM fluidics, EVA AVETA™ trocar cannula system with Push-Fit infusion connection, TDC (two-dimensional cutting) vitrectome with cut speeds of up to 16,000 CPM, EVA INICIO™ microinjection system, and an extensive range of anterior and posterior instruments including 27G ULTRA for no compromise small gauge surgery, as well as a wide range of highly purified anterior and posterior surgical liquids and tamponades. Inspired by you – created by D.O.R.C.

D.O.R.C. International

D.O.R.C. enhances global eye surgery and maximises surgeon control by offering innovative quality approaches for eye disorders. Our product portfolio includes EVA NEXUS™ phaco-vitrectomy system featuring unique VTi pump offering both FLOW and VACUUM fluidics, EVA AVETA™ trocar cannula system with Push-Fit infusion connection, TDC (two-dimensional cutting) vitrectome with cut speeds of up to 16,000 CPM, EVA INICIO™ microinjection system, and an extensive range of anterior and posterior instruments including 27G ULTRA for no compromise small gauge surgery, as well as a wide range of highly purified anterior and posterior surgical liquids and tamponades. Inspired by you – created by D.O.R.C.

Eye Care Network

Ophthalmology Times Europe presents cutting-edge advancements in surgery, drug therapy, technology and clinical diagnosis to elevate progressive eye health from doctor to patient.

Eye Care Network

Ophthalmology Times Europe presents cutting-edge advancements in surgery, drug therapy, technology and clinical diagnosis to elevate progressive eye health from doctor to patient.

Early Sight S.a.

EarlySight aims to reduce vision loss by enabling efficient detection and better monitoring of eye diseases. The company develops a high-performance eye imaging instrument empowering doctors to see the first impacts of diseases.

Early Sight S.a.

EarlySight aims to reduce vision loss by enabling efficient detection and better monitoring of eye diseases. The company develops a high-performance eye imaging instrument empowering doctors to see the first impacts of diseases.

ERN-EYE

ERN-EYE is a European reference network dedicated to Rare Eye Diseases. ERN-EYE covers 24 out of 27 EU countries, with 52 full members and 8 affiliated partners, across European Union to guarantee the best coverage of more than 900 Rare Eye Diseases. The coordinator is Pr Dollfus, Strasbourg, France. It focuses on improvement of patients’ diagnosis and care across EU throughout connecting and enforcing experts networking; remote medical expertise (virtual clinic); knowledge and information exchange; development of educational and training programmes; creation of a European interoperable registry and development of guidelines.

ERN-EYE

ERN-EYE is a European reference network dedicated to Rare Eye Diseases. ERN-EYE covers 24 out of 27 EU countries, with 52 full members and 8 affiliated partners, across European Union to guarantee the best coverage of more than 900 Rare Eye Diseases. The coordinator is Pr Dollfus, Strasbourg, France. It focuses on improvement of patients’ diagnosis and care across EU throughout connecting and enforcing experts networking; remote medical expertise (virtual clinic); knowledge and information exchange; development of educational and training programmes; creation of a European interoperable registry and development of guidelines.

FCI S.A.S.

FCI is a world leader in the development of a wide range of ophthalmic devices.
Since the company’s inception in 1984, FCI has been dedicated to provide physicians with innovative, high-performance and mostly exclusive products covering the fields of expertise of Oculoplasty, Dry Eye, and Retina.
FCI is a global, multi-site company with its headquarter in Paris, France, and a strong distribution network that serves more than 80 countries.
Our core business and activities involve extensive research & development and advanced manufacturing processes to enhance the effectiveness and performance of the procedures performed by our customers.
Your Patients, Our Expertise.

FCI S.A.S.

FCI is a world leader in the development of a wide range of ophthalmic devices.
Since the company’s inception in 1984, FCI has been dedicated to provide physicians with innovative, high-performance and mostly exclusive products covering the fields of expertise of Oculoplasty, Dry Eye, and Retina.
FCI is a global, multi-site company with its headquarter in Paris, France, and a strong distribution network that serves more than 80 countries.
Our core business and activities involve extensive research & development and advanced manufacturing processes to enhance the effectiveness and performance of the procedures performed by our customers.
Your Patients, Our Expertise.

Fight Retinal Blindness!

The Fight Retinal Blindness! (FRB!) Project investigates the safety and effectiveness of current and future treatments for retinal diseases, including macular degeneration, choroidal neovascularisation (other than nAMD), diabetic macular oedema and retinal vein occlusion. We are developing strategies and evidence-based guidelines to help reduce the incidence of retinal blindness worldwide. Established in 2009, FRB! forms the core structure for the Save Sight Registries, a web-based platform that allows clinicians to record data on “real world” treatment outcomes for eye diseases. Clinicians who use FRB! can track and analyse their patients’ treatment outcomes, audit their outcomes against other clinicians in the system and participate in local and international analyses using FRB! data. FRB! is easy to use and free to join. Visit savesightregistries.org for further information or to register.

Fight Retinal Blindness!

The Fight Retinal Blindness! (FRB!) Project investigates the safety and effectiveness of current and future treatments for retinal diseases, including macular degeneration, choroidal neovascularisation (other than nAMD), diabetic macular oedema and retinal vein occlusion. We are developing strategies and evidence-based guidelines to help reduce the incidence of retinal blindness worldwide. Established in 2009, FRB! forms the core structure for the Save Sight Registries, a web-based platform that allows clinicians to record data on “real world” treatment outcomes for eye diseases. Clinicians who use FRB! can track and analyse their patients’ treatment outcomes, audit their outcomes against other clinicians in the system and participate in local and international analyses using FRB! data. FRB! is easy to use and free to join. Visit savesightregistries.org for further information or to register.

Geuder AG

Geuder AG is a leading German manufacturer of ophthalmic surgical instruments and systems as well as provider for highly purified biomaterials. The broad portfolio of 3.000 products distributed in more than 100 countries includes a wide range of surgical equipment for the anterior and posterior segments of the eye, along with highly innovative biomaterials for retinal and cataract surgery developed and produced by our affiliated company Fluoron GmbH. We are always keeping our goal to provide the highest level of quality, precision and reliability while complying with regulatory and surgeons’ requirements to serve the patient’s expectations and well-being.

Geunder AG

Geuder AG is a leading German manufacturer of ophthalmic surgical instruments and systems as well as provider for highly purified biomaterials. The broad portfolio of 3.000 products distributed in more than 100 countries includes a wide range of surgical equipment for the anterior and posterior segments of the eye, along with highly innovative biomaterials for retinal and cataract surgery developed and produced by our affiliated company Fluoron GmbH. We are always keeping our goal to provide the highest level of quality, precision and reliability while complying with regulatory and surgeons’ requirements to serve the patient’s expectations and well-being.

Heidelberg Engineering GmbH

Heidelberg Engineering continuously optimizes imaging and healthcare IT technologies to provide ophthalmic diagnostic solutions that empower clinicians to improve patient care. From its inception in 1990, the company has collaborated with scientists, clinicians and industry to develop innovative products that deliver clinically relevant benefits.
Uncompromising quality and education play a large part in fostering the diagnostic confidence that has become synonymous with the global brand. The company’s substantial expertise in the development and implementation of intelligent image and data management solutions complements its distinguished history in the design, manufacture and distribution of ophthalmic diagnostic instruments.
Heidelberg Engineering’s growing product portfolio combines these core technologies: confocal microscopy, scanning lasers and optics, optical coherence tomography (OCT), real-time image processing and analytics, multimodal image management solutions (PACS), electronic medical records (EMR) and large-scale data analysis.

Heidelberg Engineering GmbH

Heidelberg Engineering continuously optimizes imaging and healthcare IT technologies to provide ophthalmic diagnostic solutions that empower clinicians to improve patient care. From its inception in 1990, the company has collaborated with scientists, clinicians and industry to develop innovative products that deliver clinically relevant benefits.
Uncompromising quality and education play a large part in fostering the diagnostic confidence that has become synonymous with the global brand. The company’s substantial expertise in the development and implementation of intelligent image and data management solutions complements its distinguished history in the design, manufacture and distribution of ophthalmic diagnostic instruments.
Heidelberg Engineering’s growing product portfolio combines these core technologies: confocal microscopy, scanning lasers and optics, optical coherence tomography (OCT), real-time image processing and analytics, multimodal image management solutions (PACS), electronic medical records (EMR) and large-scale data analysis.

Horus PHARMA

Horus Pharma is a French laboratory, founded in 2003.
Independent and family-owned company, we are focused on ophthalmology, acting in several countries across Europe. The Horus Pharma group is directly present in Spain, Belgium, the Netherlands, Luxembourg, and Switzerland. Our portfolio is also available in Italy, the UK, Germany, and Morocco, thanks to our key partners.
Our key strength is innovation related to a high-performing R&D policy.
We are covering all the therapeutic segments including glaucoma, retina, and cornea.
Acting both in pharmaceutical and surgical markets, we are a pioneer in the preservative-free culture. As a patient-oriented company, we strongly believe that the future relies not only on the strength of our innovative products, but also on the digitalization of our company, allowing us to bring service to the industry.
Patient-oriented, Horus Pharma is bringing broad, consistent, and innovative products and services to the European market.

Horus PHARMA

Horus Pharma is a French laboratory, founded in 2003.
Independent and family-owned company, we are focused on ophthalmology, acting in several countries across Europe. The Horus Pharma group is directly present in Spain, Belgium, the Netherlands, Luxembourg, and Switzerland. Our portfolio is also available in Italy, the UK, Germany, and Morocco, thanks to our key partners.
Our key strength is innovation related to a high-performing R&D policy.
We are covering all the therapeutic segments including glaucoma, retina, and cornea.
Acting both in pharmaceutical and surgical markets, we are a pioneer in the preservative-free culture. As a patient-oriented company, we strongly believe that the future relies not only on the strength of our innovative products, but also on the digitalization of our company, allowing us to bring service to the industry.
Patient-oriented, Horus Pharma is bringing broad, consistent, and innovative products and services to the European market.

iCare

iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). Our devices cover automated fundus imaging systems, perimeters, and handheld rebound tonometers. iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.
We believe that ophthalmic care must be accessible, effortless,
and reliable, and our aim is to establish the next level of eye care.

iCare

iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). Our devices cover automated fundus imaging systems, perimeters, and handheld rebound tonometers. iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.
We believe that ophthalmic care must be accessible, effortless,
and reliable, and our aim is to establish the next level of eye care.

Incyto

A specialized manufacturer of Hollow micro-needles for Sub-retinal, Intravitreal, etc.
- Current approval range : 38G~50G
- Surface treated Titanium
- Customization Available
- Minimal Ocular Damage
- Less Reflux & Fast recovery

Incyto

A specialized manufacturer of Hollow micro-needles for Sub-retinal, Intravitreal, etc.
- Current approval range : 38G~50G
- Surface treated Titanium
- Customization Available
- Minimal Ocular Damage
- Less Reflux & Fast recovery

Iridex

Iridex provides an array of established laser-based procedures that expand ways to manage, preserve and prolong vision. Iridex lasers, delivery devices, and consumable instrumentation for treating diabetic macular edema and other retinal diseases are available in 100 countries. Iridex’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and versatile treatment for targeted sight-threatening eye conditions. The Pascal Photocoagulator, the industry-leading Pattern Scanning Laser, allows faster procedures with less pain, collateral damage, and scarring. Visit iridex.com/webinars to learn how ophthalmologists safely and effectively use Iridex products to treat a wide range of disease types and severities.

Iridex

Iridex provides an array of established laser-based procedures that expand ways to manage, preserve and prolong vision. Iridex lasers, delivery devices, and consumable instrumentation for treating diabetic macular edema and other retinal diseases are available in 100 countries. Iridex’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and versatile treatment for targeted sight-threatening eye conditions. The Pascal Photocoagulator, the industry-leading Pattern Scanning Laser, allows faster procedures with less pain, collateral damage, and scarring. Visit iridex.com/webinars to learn how ophthalmologists safely and effectively use Iridex products to treat a wide range of disease types and severities.

Iveric Bio

Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs. The Company is committed to having a positive impact on patients’ lives by delivering high-quality, safe and effective treatments designed to address debilitating retinal diseases including earlier stages of age-related macular degeneration. 
 
For more information on the Company, please visit www.ivericbio.com.

Iveric Bio

Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs. The Company is committed to having a positive impact on patients’ lives by delivering high-quality, safe and effective treatments designed toa address debilitating retinal diseases including earlier stages of age-related macular degeneration. 
 
For more information on the Company, please visit www.ivericbio.com.
 

Janssen

At Janssen we are translating our understanding of the biology behind retinal diseases into developing much needed therapies. Janssen’s clinical-stage portfolio seeks to treat a range of eye diseases, including rare inherited retinal diseases x-linked retinitis pigmentosa and achromatopsia, as well as more common conditions, such as age-related macular degeneration, diabetic retinopathy and diabetic macular edema.

Janssen

At Janssen we are translating our understanding of the biology behind retinal diseases into developing much needed therapies. Janssen’s clinical-stage portfolio seeks to treat a range of eye diseases, including rare inherited retinal diseases x-linked retinitis pigmentosa and achromatopsia, as well as more common conditions, such as age-related macular degeneration, diabetic retinopathy and diabetic macular edema.

Jaypee Brothers Medical Publishers Pvt Ltd

Jaypee Brothers Medical Publishers Pvt Ltd is South Asia’s largest and fastest growing medical publisher. Based in New Delhi, Jaypee Brothers publishes over 350 health science books and journals every year into the undergraduate, postgraduate and specialist markets worldwide. Jaypee Brothers is committed to publishing information with clarity of text, design and purpose relevant to the busy medical professional and student at realistic prices.

Jaypee Brothers Medical Publishers Pvt Ltd

Jaypee Brothers Medical Publishers Pvt Ltd is South Asia’s largest and fastest growing medical publisher. Based in New Delhi, Jaypee Brothers publishes over 350 health science books and journals every year into the undergraduate, postgraduate and specialist markets worldwide. Jaypee Brothers is committed to publishing information with clarity of text, design and purpose relevant to the busy medical professional and student at realistic prices.

Karger Publishers

Founded 131 years ago, Karger Publishers is a worldwide publisher of scientific and medical content based in Switzerland. Karger’s ophthalmic publications address the management of retinal diseases using new imaging methods or case reports in therapy as well as surgical treatment of, for example, ophthalmic cancer. Our journals include Ophthalmologica, the official journal of EURETINA, Ocular Oncology and Pathology, Ophthalmic Research, and more, and books including Developments in Ophthalmology. Ophthalmologists will find a variety of highly relevant content in our ophthalmology portfolio.

Karger Publishers

Founded 131 years ago, Karger Publishers is a worldwide publisher of scientific and medical content based in Switzerland. Karger’s ophthalmic publications address the management of retinal diseases using new imaging methods or case reports in therapy as well as surgical treatment of, for example, ophthalmic cancer. Our journals include Ophthalmologica, the official journal of EURETINA, Ocular Oncology and Pathology, Ophthalmic Research, and more, and books including Developments in Ophthalmology. Ophthalmologists will find a variety of highly relevant content in our ophthalmology portfolio.

LKC Technologies Inc

When vision issues impact your everyday life, LKC Technologies is here to help. Building on 45 years of experience in the visual electrophysiology space, LKC’s flagship product, the RETeval™ device, brings comprehensive electrophysiology technology to any office or clinical setting. LKC Technologies is committed to developing innovative products that lead to the preservation and treatment of sight in complex and hereditary diseases, but also in more common diseases such as Diabetic Retinopathy or Glaucoma. Visit our website and visit us at our booth!

LKC Technologies Inc

When vision issues impact your everyday life, LKC Technologies is here to help. Building on 45 years of experience in the visual electrophysiology space, LKC’s flagship product, the RETeval™ device, brings comprehensive electrophysiology technology to any office or clinical setting. LKC Technologies is committed to developing innovative products that lead to the preservation and treatment of sight in complex and hereditary diseases, but also in more common diseases such as Diabetic Retinopathy or Glaucoma. Visit our website and visit us at our booth!

Lumibird Medical

Founded in 1993, Quantel Medical has been a prominent player in the field of ophthalmology for over 15 years. It develops, manufactures and markets innovative medical laser and ultrasound solutions. In July 2020, the group Lumibird Medical acquired Ellex, an Australian company active in Japan and the United States. Like Quantel Medical, Ellex is well respected within the international ophthalmology market and brings with it a host of experience in the field.
Together, Quantel Medical and Ellex, united together under the Lumibird Medical entity, have become the world leader in ophthalmology, with a presence in over 110 countries, either directly or via a distributor network. Their range of lasers and ultrasound machines are designed to diagnose and treat the four main causes of blindness: cataracts, glaucoma, diabetic retinopathy and macular degeneration. The two entities also offer a range of devices to diagnose and treat dry eye

Lumibird Medical

Founded in 1993, Quantel Medical has been a prominent player in the field of ophthalmology for over 15 years. It develops, manufactures and markets innovative medical laser and ultrasound solutions. In July 2020, the group Lumibird Medical acquired Ellex, an Australian company active in Japan and the United States. Like Quantel Medical, Ellex is well respected within the international ophthalmology market and brings with it a host of experience in the field.
Together, Quantel Medical and Ellex, united together under the Lumibird Medical entity, have become the world leader in ophthalmology, with a presence in over 110 countries, either directly or via a distributor network. Their range of lasers and ultrasound machines are designed to diagnose and treat the four main causes of blindness: cataracts, glaucoma, diabetic retinopathy and macular degeneration. The two entities also offer a range of devices to diagnose and treat dry eye

LumiThera, Inc.

LumiThera® is a medical device company focused on treating patients affected by ocular damage and disease, including dry age-related macular degeneration. LumiThera’s flagship product, the Valeda® Light Delivery System, is the first approved treatment for dry AMD using photobiomodulation in the EU. Valeda improves visual acuity, improves contrast sensitivity, reduces central drusen volume, and is designed for ease-of-use in the clinician’s office. LumiThera also offers the Diopsys electrophysiology (ERG) device to help clinicians analyze the entire visual pathway for visual and neuro-visual disorders. Visit the LumiThera stand to learn more about this comprehensive solution to diagnose, treat, and monitor patients.

LumiThera, Inc.

LumiThera® is a medical device company focused on treating patients affected by ocular damage and disease, including dry age-related macular degeneration. LumiThera’s flagship product, the Valeda® Light Delivery System, is the first approved treatment for dry AMD using photobiomodulation in the EU. Valeda improves visual acuity, improves contrast sensitivity, reduces central drusen volume, and is designed for ease-of-use in the clinician’s office. LumiThera also offers the Diopsys electrophysiology (ERG) device to help clinicians analyze the entire visual pathway for visual and neuro-visual disorders. Visit the LumiThera stand to learn more about this comprehensive solution to diagnose, treat, and monitor patients.

Luneau Technology VISIONIX

Luneau Technology Optovue and Nextsight are now Visionix.
Our new brand, Visionix, represents a breadth of resources to provide Eye Care Professionals with sophisticated technology, all from one source.
We create intelligent diagnostic, screening, and refraction for ophthalmologists and optometrists.
Our products are so intuitive and effective, they allow early detection of eye diseases like diabetes, glaucoma, and advanced macular degeneration (AMD), and can complete thousands of scans a second.

Luneau Technology VISIONIX

Luneau Technology Optovue and Nextsight are now Visionix.
Our new brand, Visionix, represents a breadth of resources to provide Eye Care Professionals with sophisticated technology, all from one source.
We create intelligent diagnostic, screening, and refraction for ophthalmologists and optometrists.
Our products are so intuitive and effective, they allow early detection of eye diseases like diabetes, glaucoma, and advanced macular degeneration (AMD), and can complete thousands of scans a second.

LUTRONIC

Lutronic is a laser medical device company founded in 1997. Our company is developing various treatments to contribute to improving the quality of human life with creative medical technology. Our subsidiary, Lutronic Vision, was established for eye health care, is currently bringing to market the world’s first laser for Selective Retina Therapy named R:GEN for the treatment of retinal diseases such as CSC, DME, and Dry AMD. We are actively seeking like-minded partners to grow and flourish with us. Please visit "Lutronic Booth" if you are interested in our laser device, R:GEN. https://vision.lutronic.com/

LUTRONIC

Lutronic is a laser medical device company founded in 1997. Our company is developing various treatments to contribute to improving the quality of human life with creative medical technology. Our subsidiary, Lutronic Vision, was established for eye health care, is currently bringing to market the world’s first laser for Selective Retina Therapy named R:GEN for the treatment of retinal diseases such as CSC, DME, and Dry AMD. We are actively seeking like-minded partners to grow and flourish with us. Please visit "Lutronic Booth" if you are interested in our laser device, R:GEN. https://vision.lutronic.com/

MedOne Surgical

MedOne’s unique cannula products enable you to tackle a wide variety of challenging retina cases using 23, 25, and 27 gauge systems. Our specialty cannulas, backflush instruments, silicone oil injection/removal products, DualBore SideFlō® Cannulas, MicroDose™ Injector and an extensive line of Subretinal cannulas, help you achieve your surgical goals.

MedOne Surgical

MedOne’s unique cannula products enable you to tackle a wide variety of challenging retina cases using 23, 25, and 27 gauge systems. Our specialty cannulas, backflush instruments, silicone oil injection/removal products, DualBore SideFlō® Cannulas, MicroDose™ Injector and an extensive line of Subretinal cannulas, help you achieve your surgical goals.

Metrovision

Metrovision offers a complete line of products dedicated to the evaluation of visual functions for clinical and research purposes.
Our products perform advanced vision psychophysics, vision electrophysiology and eye movement recording.
MonCvONE is a full field projection perimeter available in 4 versions from the basic to the most complete features:
- SAP for Standard Automated Perimetry.
- PRO (PROfessional) includes Goldmann perimetry and binocular video imaging
- CR (Clinical Research) adds the ability to perform perimetry under scotopic, mesopic and photopic levels, dark adaptometry, FST, chromatic and local pupillometry, an ideal combination for gene therapy clinical trials
- CR++ with vision electrophysiology
MonPackONE is a multifunction instrument combining several tests in one compact unit
- Psychophysics: visual field perimetry, contrast sensitivity, dark adaptation
- Electrophysiology: ganzfeld flash, pattern and multifocal ERG and VEP
- Eye movements: video oculography, scan path analysis (with IReST reading test), pupillometry

Metrovision

Metrovision offers a complete line of products dedicated to the evaluation of visual functions for clinical and research purposes.
Our products perform advanced vision psychophysics, vision electrophysiology and eye movement recording.
MonCvONE is a full field projection perimeter available in 4 versions from the basic to the most complete features:
- SAP for Standard Automated Perimetry.
- PRO (PROfessional) includes Goldmann perimetry and binocular video imaging
- CR (Clinical Research) adds the ability to perform perimetry under scotopic, mesopic and photopic levels, dark adaptometry, FST, chromatic and local pupillometry, an ideal combination for gene therapy clinical trials
- CR++ with vision electrophysiology
MonPackONE is a multifunction instrument combining several tests in one compact unit
- Psychophysics: visual field perimetry, contrast sensitivity, dark adaptation
- Electrophysiology: ganzfeld flash, pattern and multifocal ERG and VEP
- Eye movements: video oculography, scan path analysis (with IReST reading test), pupillometry

Modulight Corporation

Manufacturing ophthalmic lasers and optics for personalized medicine and better life! 
 
Modulight Corporation (listed in NASDAQ First North) is a laser solutions provider based in Tampere, Finland and Palo Alto, CA. The company has over 20 years history of in designing and manufacturing semiconductor lasers for the most demanding applications around the globe. 
 
Modulight is a fully vertically integrated company with a laser fab in Finland, carrying CE-marked, ETL-registered, and FDA-approved private label and Modulight label products. Modulight has a mission to support ophthalmology with game-changing lasers utilizing possibilities of connectivity via IoT, to support various indications such as ocular or uveal melanoma.

Modulight Corporation

Manufacturing ophthalmic lasers and optics for personalized medicine and better life! 
 
Modulight Corporation (listed in NASDAQ First North) is a laser solutions provider based in Tampere, Finland and Palo Alto, CA. The company has over 20 years history of in designing and manufacturing semiconductor lasers for the most demanding applications around the globe. 
 
Modulight is a fully vertically integrated company with a laser fab in Finland, carrying CE-marked, ETL-registered, and FDA-approved private label and Modulight label products. Modulight has a mission to support ophthalmology with game-changing lasers utilizing possibilities of connectivity via IoT, to support various indications such as ocular or uveal melanoma.
 

NIDEK CO., LTD

NIDEK, headquartered in Gamagori, Japan, manufactures and provides a comprehensive portfolio of industry leading ophthalmic, optometric, and lens edging products. At EURETINA 2022, NIDEK is pleased to introduce our innovative products such as Mirante, Multimodal Imaging Platform SLO/OCT Combo. We cordially invite you to visit our booth at No. H5, Hall H and to join our morning symposium on 2nd September.

NIDEK CO., LTD

NIDEK, headquartered in Gamagori, Japan, manufactures and provides a comprehensive portfolio of industry leading ophthalmic, optometric, and lens edging products. At EURETINA 2022, NIDEK is pleased to introduce our innovative products such as Mirante, Multimodal Imaging Platform SLO/OCT Combo. We cordially invite you to visit our booth at No. H5, Hall H and to join our morning symposium on 2nd September.

Norlase

Norlase develops next-generation laser solutions for the treatment of retina and glaucoma diseases. Founded in Denmark, Norlase is comprised of worldwide industry experts in ophthalmology, laser technology, medical device development, and customer care. Norlase is on a mission to improve practice efficiency, patient care and physician convenience for ophthalmologists worldwide. Norlase entered the United States ophthalmic market with LEAF, a new laser photocoagulator that’s 10X smaller than existing systems and mounts directly on the slit-lamp—and LION the first fully integrated green laser and LIO.

Norlase

Norlase develops next-generation laser solutions for the treatment of retina and glaucoma diseases. Founded in Denmark, Norlase is comprised of worldwide industry experts in ophthalmology, laser technology, medical device development, and customer care. Norlase is on a mission to improve practice efficiency, patient care and physician convenience for ophthalmologists worldwide. Norlase entered the United States ophthalmic market with LEAF, a new laser photocoagulator that’s 10X smaller than existing systems and mounts directly on the slit-lamp—and LION the first fully integrated green laser and LIO.

Novartis

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 108,000 people of more than 140 nationalities work at Novartis around the world. Find out more at https://www.novartis.com.

Novartis

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 108,000 people of more than 140 nationalities work at Novartis around the world.

OCULUS Surgical

OCULUS Surgical take care of its exclusive circle of customers – ophthalmic surgeons. The product range of the SDI®/BIOM® system is constantly expanding, new high-quality lenses are being created, both reusable and disposable.
Do you know the HD Disposable LenZ for the ZEISS system? You can benefit from the OCULUS quality even if you don’t use the BIOM® system.
And check out the brand new BIOM® ready+! The world’s first disposable wide-angle viewing system has been improved.
We have more solutions for you: come and see us at booth H35

OCULUS Surgical

OCULUS Surgical take care of its exclusive circle of customers – ophthalmic surgeons. The product range of the SDI®/BIOM® system is constantly expanding, new high-quality lenses are being created, both reusable and disposable.
Do you know the HD Disposable LenZ for the ZEISS system? You can benefit from the OCULUS quality even if you don’t use the BIOM® system.
And check out the brand new BIOM® ready+! The world’s first disposable wide-angle viewing system has been improved.
We have more solutions for you: come and see us at booth H35

OD-OS GmbH

Navilas® - the only navigated retina laser available at competitive pricing and growing with your needs.

OD-OS GmbH

Navilas® - the only navigated retina laser available at competitive pricing and growing with your needs.

Oertli Instrumente AG

OERTLI® - MAKING THE DIFFERENCE IN EYE SURGERY.
Oertli develops, manufactures and distributes surgical platforms, instruments and consumables with which surgeons and OR personnel can work easier, safer and more efficient and thus achieving better results for the patient. Our ongoing innovations since 1955 and invented technologies have a long-term impact on vitreoretinal surgeries. Our all-in-one surgical platform “OS 4,” is the ideal partner for a retina surgeon. It provides many benefits: a unique 3-pump system, the latest LED technology with free colour choice, efficient vitreous body removal with the Continuous Flow Cutter and a built-in endo laser.

Oertli Instrumente AG

OERTLI® - MAKING THE DIFFERENCE IN EYE SURGERY.
Oertli develops, manufactures and distributes surgical platforms, instruments and consumables with which surgeons and OR personnel can work easier, safer and more efficient and thus achieving better results for the patient. Our ongoing innovations since 1955 and invented technologies have a long-term impact on vitreoretinal surgeries. Our all-in-one surgical platform “OS 4,” is the ideal partner for a retina surgeon. It provides many benefits: a unique 3-pump system, the latest LED technology with free colour choice, efficient vitreous body removal with the Continuous Flow Cutter and a built-in endo laser.

Okuvision GmbH

Okuvision GmbH is a leading provider in the field of ocular electrostimulation. Based in Reutlingen, Germany, the company manufactures the OkuStim® therapy-system for transcorneal electrical stimulation (TES) for degenerative retinal dystrophies such as retinitis pigmentosa (RP).
The OkuStim® therapy is the only CE-marked, topically applied treatment for RP with clinically proven safety and efficacy that can slow down the progressive loss of visual field area.
The OkuStim® therapy is available in several European countries. For further information please visit our website.

Okuvision GmbH

Okuvision GmbH is a leading provider in the field of ocular electrostimulation. Based in Reutlingen, Germany, the company manufactures the OkuStim® therapy-system for transcorneal electrical stimulation (TES) for degenerative retinal dystrophies such as retinitis pigmentosa (RP).
The OkuStim® therapy is the only CE-marked, topically applied treatment for RP with clinically proven safety and efficacy that can slow down the progressive loss of visual field area.
The OkuStim® therapy is available in several European countries. For further information please visit our website.

Optomed

Optomed is a Finnish medical technology company and a leading manufacturer of handheld fundus cameras and screening software. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of various diseases, such as rapidly increasing diabetic retinopathy. Optomed has offices in Finland, the US and China, and the company’s products are sold via various sales channels in over 60 countries globally.

Optomed

Optomed is a Finnish medical technology company and a leading manufacturer of handheld fundus cameras and screening software. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of various diseases, such as rapidly increasing diabetic retinopathy. Optomed has offices in Finland, the US and China, and the company’s products are sold via various sales channels in over 60 countries globally.

Optopol Technology Sp. z o.o.

Optopol Technology, the manufacturer of the first Spectral Domain OCT in the world, is a Polish producer of original ophthalmic equipment for professionals. We have been on the market for almost 30 years.
Recently we have launched the groundbreaking the All in One OCT and FC which combines a Fundus Camera with a complete OCT functionality, including OCT Angiongraphy, Biometry OCT and Topography OCT. At the coming conference we will be showing the REVO FC 130 featuring our ACCUTRACK technology which compensates blinks, loss of fixation and involuntary eye movements during OCT scanning. We will be delighted to see you!

Optopol Technology Sp. z o.o.

Optopol Technology, the manufacturer of the first Spectral Domain OCT in the world, is a Polish producer of original ophthalmic equipment for professionals. We have been on the market for almost 30 years.
Recently we have launched the groundbreaking the All in One OCT and FC which combines a Fundus Camera with a complete OCT functionality, including OCT Angiongraphy, Biometry OCT and Topography OCT. At the coming conference we will be showing the REVO FC 130 featuring our ACCUTRACK technology which compensates blinks, loss of fixation and involuntary eye movements during OCT scanning. We will be delighted to see you!

Optos

optomap® technology documents 82% or 200° degrees of the retina. The only retinal imaging technology capable of delivering single-capture ultra-widefield images — as defined by the International Widefield Study Group. Thousands of peer-reviewed studies confirm that optomap helps doctors more effectively discover, document, and manage retinal pathology. optomap is revolutionizing eye care by helping doctors save sight.

Optos

optomap® technology documents 82% or 200° degrees of the retina. The only retinal imaging technology capable of delivering single-capture ultra-widefield images — as defined by the International Widefield Study Group. Thousands of peer-reviewed studies confirm that optomap helps doctors more effectively discover, document, and manage retinal pathology. optomap is revolutionizing eye care by helping doctors save sight.

Oxurion NV

Oxurion is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal vascular disorders including diabetic macular edema (DME), the leading cause of vision loss in diabetic patients worldwide.

Oxurion NV

Oxurion is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal vascular disorders including diabetic macular edema (DME), the leading cause of vision loss in diabetic patients worldwide.

Phakos

PHAKOS Quality
Since its creation, PHAKOS has aimed for excellence, and we have always sought brands renowned for the quality of their products for our distribution. Constantly in this search for values, the obvious thing to do was to become a manufacturer ourselves and to certify to our users the rules of requirement and reliability of our products. This ensures us today a recognition from our users in France and around the world.

Phakos

PHAKOS Quality
Since its creation, PHAKOS has aimed for excellence, and we have always sought brands renowned for the quality of their products for our distribution. Constantly in this search for values, the obvious thing to do was to become a manufacturer ourselves and to certify to our users the rules of requirement and reliability of our products. This ensures us today a recognition from our users in France and around the world.

Retinai

RetinAI Medical AG (RetinAI) develops software solutions to accelerate and optimize clinical, research and pharmaceutical workflows, enabling stakeholders in healthcare to make the right decisions sooner. The company developed RetinAI Discovery®, a platform to collect, organize and analyze healthcare data more efficiently to extract insights and knowledge for treatment decision pathways. RetinAI Discovery is FDA-cleared and CE-Marked as a medical image and data management platform, that is cloud-based, with the capability to organize and harmonize data at-scale from multiple data sources. Discovery is also capable of automatically collecting insights using its proprietary AI models to enhance the understanding of biomarkers and key endpoints in Ophthalmic diseases and disorders.

Retinai

RetinAI Medical AG (RetinAI) develops software solutions to accelerate and optimize clinical, research and pharmaceutical workflows, enabling stakeholders in healthcare to make the right decisions sooner. The company developed RetinAI Discovery®, a platform to collect, organize and analyze healthcare data more efficiently to extract insights and knowledge for treatment decision pathways. RetinAI Discovery is FDA-cleared and CE-Marked as a medical image and data management platform, that is cloud-based, with the capability to organize and harmonize data at-scale from multiple data sources. Discovery is also capable of automatically collecting insights using its proprietary AI models to enhance the understanding of biomarkers and key endpoints in Ophthalmic diseases and disorders.

RetInSight

RetInSight is the first EU MDR certified company offering AI-based retinal image analysis. RetInSight was founded in April 2020 as a spin-off from the Department of Ophthalmology & Optometry of the Medical University of Vienna, Austria, a global pioneer in AI-based retinal image analysis and provider of reading center services for more than 15 years. The company offers transformational OCT based Artificial Intelligence solutions with a clear vision: Living longer shall not mean seeing less.

To accomplish this, RetInSight develops AI solutions for therapeutic monitoring and diagnostic screening according to the highest standards. RetInSight further owns an extensive library of validated algorithms for use in (bio)pharmaceutical clinical and scientific studies. Upon certification, these algorithms are made available for clinical practice. In this way, RetInSight helps bridge the gap between superior outcomes observed in clinical trials and inferior benefits obtained at high cost in the real world, for the leading retinal diseases of our time.

Please visit us at the RetInSight booth at EURETINA congress or our website.

RetInSight

RetInSight is the first EU MDR certified company offering AI-based retinal image analysis. RetInSight was founded in April 2020 as a spin-off from the Department of Ophthalmology & Optometry of the Medical University of Vienna, Austria, a global pioneer in AI-based retinal image analysis and provider of reading center services for more than 15 years. The company offers transformational OCT based Artificial Intelligence solutions with a clear vision: Living longer shall not mean seeing less.

To accomplish this, RetInSight develops AI solutions for therapeutic monitoring and diagnostic screening according to the highest standards. RetInSight further owns an extensive library of validated algorithms for use in (bio)pharmaceutical clinical and scientific studies. Upon certification, these algorithms are made available for clinical practice. In this way, RetInSight helps bridge the gap between superior outcomes observed in clinical trials and inferior benefits obtained at high cost in the real world, for the leading retinal diseases of our time.

Please visit us at the RetInSight booth at EURETINA congress or our website.

Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders.

Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders.

Roland Consult Stasche & Finger GmbH

Roland Consult Stasche & Finger GmbH

Samsara Medevise

Samsara Vision is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders.
We recognize that central vision loss from late-stage age-related macular degeneration (AMD) can make it difficult for individuals to connect with the world around them. Our telescopic implant technology, Smaller-Incision New Generation Implantable Miniature Telescope (SING IMT™), is intended to significantly improve central vision for late-stage AMD patients and help them regain their visual independence.

Samsara Medevise

Samsara Vision is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders.
We recognize that central vision loss from late-stage age-related macular degeneration (AMD) can make it difficult for individuals to connect with the world around them. Our telescopic implant technology, Smaller-Incision New Generation Implantable Miniature Telescope (SING IMT™), is intended to significantly improve central vision for late-stage AMD patients and help them regain their visual independence.

Surgicube International Bv

SuiteSurgery provides ultra-clean air solutions for the safe performance of surgical procedures
Are you looking for innovative ways of operative care that allow you to select and treat your patients quickly and efficiently? Do you want to be able to grow quickly with your treatment capacity and thus increase your turnover? Do you agree it is important to arrange each room as efficiently as possible and meet all hygiene requirements at the same time?
SuiteSurgery products SurgiCube®, Toul Operio® Mobile / Ceiling / Clinic and SteriStay® will do just that. Smart. Simple. Safe.

www.suitesurgery.com www.surgicube.com www.toulmeditech.com

Surgicube International Bv

SuiteSurgery provides ultra-clean air solutions for the safe performance of surgical procedures
Are you looking for innovative ways of operative care that allow you to select and treat your patients quickly and efficiently? Do you want to be able to grow quickly with your treatment capacity and thus increase your turnover? Do you agree it is important to arrange each room as efficiently as possible and meet all hygiene requirements at the same time?
SuiteSurgery products SurgiCube®, Toul Operio® Mobile / Ceiling / Clinic and SteriStay® will do just that. Smart. Simple. Safe.

www.suitesurgery.com www.surgicube.com www.toulmeditech.com

Teknomek Medikal

As the Teknomek Medikal we are a company that always produces the best and newest products and that makes significant investments in this regard in eye surgery. Teknomek Medikal has been selling eye surgery consumables with the best quality for 10 years. As a producer we have CE and ISO 13485 certified for our products.

Teknomek Medikal

As the Teknomek Medikal we are a company that always produces the best and newest products and that makes significant investments in this regard in eye surgery. Teknomek Medikal has been selling eye surgery consumables with the best quality for 10 years. As a producer we have CE and ISO 13485 certified for our products.

Théa

For the last 150 years, Théa have been pionneers in ophthalmology.
By developing treatments, providing information and sharing knowledge with specialists around the world.
Our commitment is to provide innovative products and a wide range of medicinal products to healthcare providers and patients in all ophthalmological therapeutic classes.

Théa

For the last 150 years, Théa have been pionneers in ophthalmology.
By developing treatments, providing information and sharing knowledge with specialists around the world.
Our commitment is to provide innovative products and a wide range of medicinal products to healthcare providers and patients in all ophthalmological therapeutic classes.

Topcon Healthcare

Topcon Healthcare sees eye health differently. Our vision is to empower providers with smart, value-driven and efficient technologies for enhanced care. Keeping pace with the ever-changing landscape of the healthcare industry, Topcon Healthcare offers the latest integrated solutions including advanced multimodal imaging, vendor-neutral data management and groundbreaking remote diagnostic technology.

Topcon Healthcare

Topcon Healthcare sees eye health differently. Our vision is to empower providers with smart, value-driven and efficient technologies for enhanced care. Keeping pace with the ever-changing landscape of the healthcare industry, Topcon Healthcare offers the latest integrated solutions including advanced multimodal imaging, vendor-neutral data management and groundbreaking remote diagnostic technology.

Wisepress Ltd

Wisepress.com, Europe’s leading conference bookseller, attend around 200 conferences every year. We have an extensive range of books and journals relevant to the themes of this conference available at our booth. We also have a comprehensive range of STM titles available on our online bookshop.
Follow us on Twitter @WisepressBooks.

Wisepress Ltd

Wisepress.com, Europe’s leading conference bookseller, attend around 200 conferences every year. We have an extensive range of books and journals relevant to the themes of this conference available at our booth. We also have a comprehensive range of STM titles available on our online bookshop.
Follow us on Twitter @WisepressBooks.